Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (411-420 of 451) with videos related to

Pageof 46
Sort By:
Acta Neuropathologica|April 25, 2018
Novel, improved grading system(s) for IDH-mutant astrocytic gliomasMitsuaki Shirahata, Takahiro Ono, Damian Stichel, et al.
Nature Medicine|May 17, 2024
A prognostic neural epigenetic signature in high-grade gliomaRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spreadFelix Hinz, Dennis Friedel, Andrey Korshunov, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Cell|December 7, 2024
Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracingSvenja K Tetzlaff, Ekin Reyhan, Nikolas Layer, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Pageof 46

Showing results (411-420 of 451) with videos related to

Sort By:
Pageof 46
Acta Neuropathologica|April 25, 2018
Novel, improved grading system(s) for IDH-mutant astrocytic gliomasMitsuaki Shirahata, Takahiro Ono, Damian Stichel, et al.
Nature Medicine|May 17, 2024
A prognostic neural epigenetic signature in high-grade gliomaRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spreadFelix Hinz, Dennis Friedel, Andrey Korshunov, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Cell|December 7, 2024
Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracingSvenja K Tetzlaff, Ekin Reyhan, Nikolas Layer, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Pageof 46